Pre-Market
View all rates
Back to news
General

Memphis Pharmaceuticals (MPCI.CA) - Board of Directors' Decisions

Published at 3 May 2026 at 14:04Memphis PharmaceuticalsRelated stock:Memphis Pharmaceuticals stockAll Memphis Pharmaceuticals disclosures

Disclosure summary

Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Board of Directors' decisions held on 30/04/20206 concerning the unaudited financial results for the period ended on 31/03/2026.

The BoD Decisions (1,779 KB)
The Audit Committee Report (1,819 KB)
Memphis Pharmaceuticals (MPCI.CA) - Board of Directors' Decisions | FoudaLens